A Tripartite Complex HIV-1 Tat-Cyclophilin A-Capsid Protein Enables Tat Encapsidation That Is Required for HIV-1 Infectivity

被引:7
|
作者
Schatz, Malvina [1 ]
Marty, Laetitia [1 ]
Ounadjela, Camille [1 ]
Tong, Phuoc Bao Viet [1 ]
Cardace, Ilaria [1 ]
Mettling, Clement [2 ]
Milhiet, Pierre-Emmanuel [3 ]
Costa, Luca [3 ]
Godefroy, Cedric [3 ]
Pugniere, Martine [4 ]
Guichou, Jean-Francois [3 ]
Mesnard, Jean-Michel [1 ]
Blaise, Mickael [1 ]
Beaumelle, Bruno [1 ]
机构
[1] Univ Montpellier, Inst Rech Infectiol Montpellier, UMR CNRS 9004, Montpellier, France
[2] Inst Genet Humaine, UPR CNRS 1142, Montpellier, France
[3] Univ Montpellier, Ctr Biol Struct, CNRS, INSERM, Montpellier, France
[4] Inst Rech Cancerol Montpellier, INSERM U 1194, Montpellier, France
关键词
capsid; HIV-1; Tat; cores; cyclophilin A; virions; IMMUNODEFICIENCY-VIRUS TYPE-1; CYCLOSPORINE-A; DEPENDENT STEPS; LIFE-CYCLE; TRANSCRIPTION; BINDING; ACETYLTRANSFERASE; TRANSACTIVATOR; REPLICATION; RESTRICTION;
D O I
10.1128/jvi.00278-23
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HIV-1 Tat is a key viral protein that stimulates several steps of viral gene expression. Tat is especially required for the transcription of viral genes. Nevertheless, it is still not clear if and how Tat is incorporated into HIV-1 virions. Cyclophilin A (CypA) is a prolyl isomerase that binds to HIV-1 capsid protein (CA) and is thereby encapsidated at the level of 200 to 250 copies of CypA/virion. Here, we found that a Tat-CypA-CA tripartite complex assembles in HIV-1-infected cells and allows Tat encapsidation into HIV virions (1 Tat/1 CypA). Biochemical and biophysical studies showed that high-affinity interactions drive the assembly of the Tat-CypA-CA complex that could be purified by size exclusion chromatography. We prepared different types of viruses devoid of transcriptionally active Tat. They showed a 5- to 10 fold decrease in HIV infectivity, and conversely, encapsidating Tat into Delta Tat viruses greatly enhanced infectivity. The absence of encapsidated Tat decreased the efficiency of reverse transcription by similar to 50% and transcription by more than 90%. We thus identified a Tat-CypA-CA complex that enables Tat encapsidation and showed that encapsidated Tat is required to initiate robust viral transcription and thus viral production at the beginning of cell infection, before neosynthesized Tat becomes available.IMPORTANCE The viral transactivating protein Tat has been shown to stimulate several steps of HIV gene expression. It was found to facilitate reverse transcription. Moreover, Tat is strictly required for the transcription of viral genes. Although the presence of Tat within HIV virions would undoubtedly favor these steps and therefore enable the incoming virus to boost initial viral production, whether and how Tat is present within virions has been a matter a debate. We here described and characterized a tripartite complex between Tat, HIV capsid protein, and the cellular chaperone cyclophilin A that enables efficient and specific Tat encapsidation within HIV virions. We further showed that Tat encapsidation is required for the virus to efficiently initiate infection and viral production. This effect is mainly due to the transcriptional activity of Tat.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] HIV-1 Tat Length: Comparative and Functional Considerations
    Mele, Anthony R.
    Marino, Jamie
    Dampier, Will
    Wigdahl, Brian
    Nonnemacher, Michael R.
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [22] In vitro selection of HIV-1 TAR variants by the Tat protein
    Marozzi, A
    Meneveri, R
    Giacca, M
    Gutierrez, MI
    Siccardi, AG
    Ginelli, E
    JOURNAL OF BIOTECHNOLOGY, 1998, 61 (02) : 117 - 128
  • [23] A review of HIV-1 Tat protein biological effects
    Pugliese, A
    Vidotto, V
    Beltramo, T
    Petrini, S
    Torre, D
    CELL BIOCHEMISTRY AND FUNCTION, 2005, 23 (04) : 223 - 227
  • [24] Molecular dynamics simulations on HIV-1 Tat
    Pantano, S
    Tyagi, M
    Giacca, M
    Carloni, P
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2004, 33 (04): : 344 - 351
  • [25] HIV-1 Tat: Role in Bystander Toxicity
    Ajasin, David
    Eugenin, Eliseo A.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [26] A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1
    Lin, Min-Hsuan
    Sivakumaran, Haran
    Jones, Alun
    Li, Dongsheng
    Harper, Callista
    Wei, Ting
    Jin, Hongping
    Rustanti, Lina
    Meunier, Frederic A.
    Spann, Kirsten
    Harrich, David
    RETROVIROLOGY, 2014, 11
  • [27] Conformational diversity in the intrinsically disordered HIV-1 Tat protein induced by zinc and pH
    Kunihara, Tomoko
    Hayashi, Yuuki
    Arai, Munehito
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 509 (02) : 564 - 569
  • [28] Targeting Tat-TAR RNA Interaction for HIV-1 Inhibition
    Alanazi, Awadh
    Ivanov, Andrey
    Kumari, Namita
    Lin, Xionghao
    Wang, Songping
    Kovalskyy, Dmytro
    Nekhai, Sergei
    VIRUSES-BASEL, 2021, 13 (10):
  • [29] Identification of small molecule modulators of HIV-1 Tat and Rev protein accumulation
    Balachandran, Ahalya
    Wong, Raymond
    Stoilov, Peter
    Pan, Sandy
    Blencowe, Benjamin
    Cheung, Peter
    Harrigan, P. Richard
    Cochrane, Alan
    RETROVIROLOGY, 2017, 14
  • [30] Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
    Ghezzi, S
    Noonan, DM
    Aluigi, MG
    Vallanti, G
    Cota, M
    Benelli, R
    Morini, M
    Reeves, JD
    Vicenzi, E
    Poli, G
    Albini, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 270 (03) : 992 - 996